Amneal Pharmaceuticals

• Amneal Pharmaceuticals Logo.svg

  Amneal Pharmaceuticals Logo

• 

  Amneal Pharmaceuticals Ibuprofen Tablets

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a publicly traded American pharmaceutical company that develops, manufactures, and distributes generic and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and operates globally.

History

Amneal Pharmaceuticals was founded in 2002 by brothers Chirag and Chintu Patel. The company began as a small generics manufacturer and quickly expanded its operations through strategic acquisitions and organic growth. In 2018, Amneal completed a merger with Impax Laboratories, significantly increasing its product portfolio and market presence.

Operations

Amneal Pharmaceuticals operates in several key areas of the pharmaceutical industry, including the development and manufacturing of generic drugs, specialty pharmaceuticals, and over-the-counter (OTC) products. The company has manufacturing facilities in the United States, India, and Ireland, allowing it to serve a global market.

Generic Pharmaceuticals

Amneal is known for its extensive portfolio of generic pharmaceuticals, which includes a wide range of therapeutic areas such as cardiovascular, central nervous system, oncology, and anti-infectives. The company focuses on providing affordable and accessible medications to patients worldwide.

Specialty Pharmaceuticals

In addition to generics, Amneal develops and markets specialty pharmaceuticals. These products often address complex or rare medical conditions and may require specialized manufacturing processes. The company's specialty portfolio includes treatments for neurological disorders, endocrinology, and infectious diseases.

Over-the-Counter Products

Amneal also produces a variety of OTC products, which are available without a prescription. These products include analgesics, cough and cold remedies, and vitamins and supplements.

Research and Development

Amneal Pharmaceuticals invests significantly in research and development (R&D) to support its pipeline of new products. The company's R&D efforts focus on developing complex generics, innovative drug delivery systems, and new specialty pharmaceuticals. Amneal's R&D facilities are equipped with state-of-the-art technology to support these initiatives.

Corporate Social Responsibility

Amneal is committed to corporate social responsibility and engages in various initiatives to support community health and well-being. The company participates in charitable activities, supports healthcare education, and promotes environmental sustainability in its operations.

Related pages

• Generic drug
• Pharmaceutical industry
• Specialty pharmaceuticals
• Over-the-counter drug

Template:Companies listed on NASDAQ